Results 91 to 100 of about 247,168 (212)

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies

open access: yesCancer Immunology, Immunotherapy
Tissue factor (TF) is a cell surface protein that plays a role in blood clotting but is also commonly expressed in many cancers. Recent research implicated TF in cancer proliferation, metastasis, angiogenesis, and immune escape.
Seiichiro Takao   +10 more
doaj   +1 more source

Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer

open access: yesEBioMedicine, 2020
Background: Small cell lung cancer (SCLC) has a poor prognosis, and its treatment options are limited. Delta-like protein 3 (DLL3) is expressed specifically in SCLC and is considered a promising therapeutic target for patients with this disease ...
Yoshitaka Isobe   +16 more
doaj   +1 more source

Comparison of the Effectiveness of IgG Antibody versus F(ab′)2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy

open access: yes, 2022
Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer treatment modality that utilizes antibody-photoabsorber conjugates (APCs) and selectively kills target cells after irradiation with NIR light.
Ryuhei Okada (7419425)   +8 more
core   +1 more source

Disease‐Stage Synchronized Nanozyme Therapy for Polymicrobial Sepsis through Adaptive Catalytic and Immune Reprogramming

open access: yesAdvanced Science, EarlyView.
A disease‐stage synchronized nanozyme platform is developed to treat polymicrobial sepsis by adapting its functions to changing infection environments. The system eliminates multidrug‐resistant bacteria during early infection while reducing inflammation and restoring immune balance during recovery, providing an integrated strategy for infection control
Anlai Zou   +11 more
wiley   +1 more source

Efficient Cholesteric Liquid Crystal Waveguide Polarizing Splitters for High‐Sensitivity Chip‐Scale Atomic Magnetometry

open access: yesAdvanced Science, EarlyView.
An integrated polarimetry architecture based on a cholesteric liquid crystal waveguide polarization splitter overcomes the volumetric bottleneck in chip‐scale atomic magnetometers. By leveraging Bragg‐selective reflection and total‐internal‐reflection‐induced helicity inversion, this ultrathin device enables efficient circular polarization splitting ...
Zhibo Cui   +9 more
wiley   +1 more source

Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models.

open access: yesPLoS ONE, 2020
BackgroundPhotoimmunotherapy (PIT) employs the use of a near-infrared (NIR) laser to activate an antibody conjugated to a NIR-activatable dye to induce cancer cell death. PIT has shown to be effective in a number of studies, however, there are no data on
Hannah M Hollandsworth   +6 more
doaj   +1 more source

Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin–Antibody Conjugate

open access: yes, 2018
Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective tumor treatment that uses an antibody–photoabsorber conjugate (APC). However, the effect of NIR-PIT can be enhanced when combined with other therapies.
Tadanobu Nagaya   +8 more
core   +1 more source

Advances in Se Wide‐Bandgap Photovoltaics and TexSe1‐x SWIR Photodiodes

open access: yesAdvanced Science, EarlyView.
In this review, fundamental properties and current challenges in Se photovoltaics (PVs) for tandem and indoor PVs and TexSe1‐x alloys for short wave infrared photodiodes are discussed. A case is made for the practicality of elemental chalcogenide optoelectronics, and a pathway toward resolving the key challenges in these respective technologies is ...
Adam D. Alfieri, Deep Jariwala
wiley   +1 more source

Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy

open access: yesBMC Cancer, 2012
Background Near infrared (NIR) photoimmunotherapy (PIT) is a new type of cancer treatment based on a monoclonal antibody (mAb)-NIR phthalocyanine dye, (IR700) conjugate.
Mitsunaga Makoto   +5 more
doaj   +1 more source

GFP fluorescence imaging of PIT in vivo in bilateral N87-GFP flank model.

open access: yes, 2014
(A) PIT regimen. Fluorescence images were obtained at each time point as indicated. (B) In vivo GFP fluorescence real-time imaging of bilateral flank tumor bearing mice in response to PIT. The tumor treated by PIT showed decreasing GFP fluorescence after
Hisataka Kobayashi (1859)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy